Learn about the ISN’s work in advocacy below.
ISN Urges Members of the 148th WHO Executive Board to Prioritize the Prevention and Treatment of Kidney Disease
The ISN participated in the 148th session of the WHO Executive Board, which took place virtually from January 18-26, 2021. The ISN submitted four statements on: Oral health and its correlation with kidney and cardiovascular diseases Social determinants of health Prevention and control of diabetes Read the full statements here. The first two statements, one of...
Statement by the International Society of Nephrology on Social Determinants of Health at the WHO 148th Executive Board
Honorable chair, distinguished delegates, The International Society of Nephrology (ISN) urges the WHO and member states to accelerate action to tackle the social determinants of health. Chronic kidney disease (CKD) is the highest risk comorbidity for severity of illness and death from COVID-191, and disproportionately affects the poor and disenfranchised. The social gradient impacts outcomes...
Statement by the Global Coalition for Circulatory Health supported by the International Society for Nephrology at the WHO 148th Executive Board
World Health Organization Executive Board 148th Session Agenda Item 6: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases Oral Health As Members of the Global Coalition for Circulatory Health, the World Heart Federation, International Diabetes Federation, International Society for Nephrology, and World Stroke Organization thank you...
Bridging the Gaps: Your New, ISN Advocacy Quarterly Newsletter – January 2021
BRIDGING THE GAPS: ISN ADVOCACY TACKLES THE GLOBAL BURDEN OF KIDNEY DISEASE Welcome, members and allies, to the inaugural edition of Bridging the Gaps, the ISN’s quarterly update on how we’re advocating and collaborating with partners to tackle the global burden of kidney disease. As you know, about 850 million people worldwide have some sort of...